Waj al-Zahr (pain in lower back) is typically defined as pain in the lumbo-sacral area of the back which is sometimes radiated to the lower extremities of the body including buttocks, hips, thighs and legs. It is usually caused by muscle strain, degenerative disorders of vertebral column, herniated vertebral discs, gynaecological disorders in females etc. In Unani Medicine, the low back pain is known as Waj al-Zahr which is dealt under Waj al-Mafasil (arthritis). Regimenal therapy is one such core mode of treatment through which the morbid humour is diverted/ eliminated or its excessive production is checked or its spread is arrested and ultimately resolved by tabiyat (physic) of the body. Inkibab (steam application) and Hijama Muzliqa (massage cupping) are regimenal modes which are being used for the treatment of various diseases including Waj al-Zahr. A 23 year old female patient was admitted in the IPD of Regional Research Institute of Unani Medicine, Srinagar, J & K, with the chief complaint of pain in lower back. She was treated by Inkibab (steam application) from the decoction of Gul-e-Teesu (Butea monosperma flowers) and Hijama Muzliqa (massage cupping) daily for six days. At the end of the treatment and post treatment follow ups, the patient got complete relief from lower back pain. Therefore, this study suggests that Inkibab and Hijama Muzliqa may be useful in the treatment of Waj al-Zahr (Non-specific low back pain).
Diabetes mellitus (DM) is a chronic metabolic disease characterized by hyperglycaemia due to absolute or relative deficiency of insulin. Nearly 382 million people have been suffered from DM by 2013 AD, which may increase up to 592 million by 2035 AD. The main clinical presentations of DM are polyuria, polydipsia and polyphagia. This disease can produce many complications such as diabetic ketoacidosis, retinopathy, renal failure, peripheral neuropathy, autonomic neuropathy, arthropathy, hyperosmolar nonketotic coma, diabetic foot, myocardial ischemia, intermittent claudication etc. In Unani Medicine, diabetes mellitus is referred as Dhayābītus Shakri (DS), which has been classified under ‘Amraz-iKulyā’ (renal diseases) on the basis of clinical presentations such as polyuria and glycosuria. In this case, Qurs-i-Ziabetus Khas, a pharmacopoeial compound drug, two tablets twice in a day just before meal was given orally to a newly diagnosed case of DM for a period of two months. The clinical features such as polyuria and polydipsia, and laboratory parameters such as fasting blood glucose level, postprandial blood sugar level, HbA1c and mean plasma glucose level were assessed. His clinical features were completely subsided; and blood sugar levels, HbA1c and mean plasma glucose level were significantly decreased. Hence, the study is suggested that Qurs-i-Ziabetus Khas may be given to patients of diabetes mellitus under medical supervision for better compliance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.